gms | German Medical Science

21. Jahrestagung der Retinologischen Gesellschaft gemeinsam mit dem
8. Symposium der International Society of Ocular Trauma

Deutsche Gesellschaft für Retinologie
International Society of Ocular Trauma

19.06. - 22.06.2008, Würzburg

„Bonner record form” – documentation of all relevant parameters during Anti-VEGF-therapy

Meeting Abstract

Suche in Medline nach

  • Carsten H. Meyer - Bonn/Germany
  • F.G. Holz - Bonn/Germany

Retinologische Gesellschaft. International Society of Ocular Trauma. 21. Jahrestagung der Retinologischen Gesellschaft gemeinsam mit dem 8. Symposium der International Society of Ocular Trauma. Würzburg, 19.-22.06.2008. Düsseldorf: German Medical Science GMS Publishing House; 2008. DocISOTRG2008P10

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 18. Juni 2008

© 2008 Meyer et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



Background: Intravitreal injections have become the most frequent treatment approach for vascular retinal disease. The main important clinical features of the fluorescein angiography (FA), optical coherence tomography (OCT), fundus examination and best corrected visual acuity (BCVA) are commonly documented in a non-structured manor during base line examination as well as repeated follow-up examinations.

Methods: We designed a novel patient record form including the essential values of each visit. The top of the page contains the personal dates including name of the patient, date of birth,referring physician, insurance company, (OD/OS), type of disease as well as chosen anti-VEGF agent. Below, there is a table containing a column for each visit to document the subjective VA of the patient the obtained BCVA, the central retinal thickness as well as a description of the tomographic feature, type of CNV, amount of leakage. Disease progression e.g. hemorrhages, RPE-tears are also recorded at each visit. The final line gives space for further recommendations: next follow-up appointment, next treatment date or delay by the involved insurance company.

Results: The novel Bonner patients\'27 record is an excellent tool to document the results of repeated uniform examinations. A study of a conventional patient chart takes several minutes to generate the essential information regarding the initial and latest key features on numerous pages and sheets. However, our patient record form highlights the essential values at each follow-up visit. In addition gives a graphic chart an immediate overview of the funcional and anatomical status. The compact overview helps to make a solid decision for or against another intravitreal injection in a well-organized manor.

Conclusion: We designed for anti-VEGF-patients a structured record form similar to well-established graphic charts for glaucoma patients. The Bonner patients\'27 record form is a valuable tool to document the key features of a stringent algorithm at each visit.